Patients with Severe RSV Outcomes
Overall, 77 (19.1%) of the 403 patients experienced severe illness
including 66 (16.4%) who were admitted to an ICU, 50 (12.4%) who
received mechanical ventilation, and/or 27 (6.7%) who died during
hospitalization. The median length of ICU stay was seven days (IQR 3.5
to 12 days) and the median duration of mechanical ventilation was three
days (IQR 2 to 9.5 days).
The number of patients hospitalized with laboratory-confirmed RSV
infection ranged from 4-92 each month and the number of patients with
severe illness ranged from 0-21 each month (Figure 1). Both surveillance
years, the number of patients hospitalized with RSV infection was
highest in December and January. The proportion of patients with severe
RSV outcomes each year and each month were similar.